Method of treating fibrotic disorders
AssigneeBaker Cummins Dermatologicals, Inc.
InventorsBrian Berman, Matthew R. Duncan
Life of this patent
Estimating the term…
Abstract
A novel method of treating fibrotic disorders in humans comprises the administration of a sufficient quantity of a composition containing a human alpha- or beta-interferon to raise the total concentration of such interferon in the affected tissue area to about 10 to about 4.times.10.sup.7 IU per cubic centimeter. The interferons used can be naturally derived or recombinant DNA-derived. The interferon composition can be administered by any indicated conventional method and can include any pharmaceutically acceptable, interferon-compatible vehicle.
Claims10
A method of treating a human patient suffering from cutaneous keloid formation in a tissue area to reduce and degrade the keloid lesions comprising the administration to the patient of a sufficiently quantity of a composition containing a human alpha.sub.2b -interferon to raise the total concentration of such interferon in the tissue area to 10 to 4.times.10.sup.7 international units per cubic centimeter.
A method according to claim 11 wherein said composition is injected intralesionally.
Dependencies are inferred from the claim text.